Nicox NICXF Stock
Nicox Price Chart
Nicox NICXF Financial and Trading Overview
| Nicox stock price | 0.44 USD |
| Previous Close | 0.64 USD |
| Open | 0.64 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.64 - 0.64 USD |
| 52 Week Range | 0.64 - 1.77 USD |
| Volume | 1K USD |
| Avg. Volume | 15 USD |
| Market Cap | 31.92M USD |
| Beta (5Y Monthly) | 0.94521 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NICXF Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | -0.96393937 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.758017 |
| Price/Book (mrq) | 0.4528114 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Nicox Stock Price History
| Beta (5Y Monthly) | 0.94521 |
| 52-Week Change | -63.84% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.77 USD |
| 52 Week Low | 0.64 USD |
| 50-Day Moving Average | 0.64 USD |
| 200-Day Moving Average | 1.13 USD |
NICXF Share Statistics
| Avg. Volume (3 month) | 15 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 50.17M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 6.32% |
| % Held by Institutions | 8.26% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -708.98% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -13.95% |
| Return on Equity (ttm) | -43.37% |
Income Statement
| Revenue (ttm) | 3.27M USD |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | -68.89% |
| Gross Profit (ttm) | -14721000 USD |
| EBITDA | -21530000 USD |
| Net Income Avi to Common (ttm) | -27759000 USD |
| Diluted EPS (ttm) | -0.67 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 27.65M USD |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | 21.33M USD |
| Total Debt/Equity (mrq) | 40.69 USD |
| Current Ratio (mrq) | 4.105 |
| Book Value Per Share (mrq) | 1.405 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Nicox
| Country | United States |
| State | N/A |
| City | Valbonne |
| Address | 2405 Route Des Dolines |
| ZIP | 06560 |
| Phone | 33 4 97 24 53 00 |
| Website | https://www.nicox.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Nicox S.A. operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial. The company is also developing NCX 4251, a novel patented ophthalmic suspension of fluticasone propionate nanocrystals that is in Phase 2b clinical trial for the treatment of dry eye disease; and NCX 1728, an NO-donating Phosphodiesterase-5 inhibitor, which is in preclinical evaluation. It offers VYZULTA, a latanoprostene bunod ophthalmic solution to treat patients with open-angle glaucoma or ocular hypertension; and ZERVIATE, a cetirizine ophthalmic solution for the treatment of ocular itching associated with allergic conjunctivitis. The company was incorporated in 1996 and is headquartered in Valbonne, France.
Q&A For Nicox Stock
What is a current NICXF stock price?
Nicox NICXF stock price today per share is 0.44 USD.
How to purchase Nicox stock?
You can buy NICXF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nicox?
The stock symbol or ticker of Nicox is NICXF.
Which industry does the Nicox company belong to?
The Nicox industry is Biotechnology.
How many shares does Nicox have in circulation?
The max supply of Nicox shares is 50.3M.
What is Nicox Price to Earnings Ratio (PE Ratio)?
Nicox PE Ratio is now.
What was Nicox earnings per share over the trailing 12 months (TTM)?
Nicox EPS is -0.4 USD over the trailing 12 months.
Which sector does the Nicox company belong to?
The Nicox sector is Healthcare.